Starpharma (SPHRY) News Today $0.74 0.00 (0.00%) As of 01/29/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Starpharma Highlights DEP® Dendrimer Platform at PepTalk ConferenceJanuary 15, 2025 | tipranks.comStarpharma CEO Receives Major Performance Rights IssuanceDecember 12, 2024 | markets.businessinsider.comStarpharma Issues Unquoted Securities to Boost Employee IncentivesDecember 12, 2024 | markets.businessinsider.comStarpharma Holdings Reports Successful AGM ResultsNovember 29, 2024 | tipranks.comStarpharma Holdings Schedules Reconvened AGM for Key VoteNovember 26, 2024 | tipranks.comStarpharma AGM Results Highlight Voting ChallengesNovember 26, 2024 | tipranks.comStarpharma Holdings Highlights Strategic Advances in 2024November 25, 2024 | tipranks.comStarpharma Highlights Dendrimer Technology at Healthcare ConferenceNovember 18, 2024 | markets.businessinsider.comStarpharma Showcases Dendrimer Innovations at Microcap ConferenceOctober 29, 2024 | markets.businessinsider.comStarpharma Holdings Ltd. ADRMarch 14, 2024 | wsj.comStarpharma's VivaGel Approval Denied By FDAFebruary 19, 2024 | markets.businessinsider.comASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pcFebruary 18, 2024 | msn.comStarpharma Holdings Ltd SPLJanuary 19, 2024 | morningstar.comStarpharma Holdings LimitedJanuary 6, 2024 | afr.comStarpharma Holdings Limited (SPHRY)November 29, 2023 | finance.yahoo.comStarpharma Holdings (SPHRY) Earnings Dates & ReportsNovember 8, 2023 | investing.comStarpharma: Patience Needed, But A Lot To LikeJuly 27, 2023 | seekingalpha.comThe Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreakJune 9, 2023 | msn.comVIRALEZE Nasal Spray to be distributed in Hong Kong and MacauOctober 24, 2022 | finance.yahoo.comStarpharma presents compelling data in Prostate Cancer at ESMOSeptember 12, 2022 | finance.yahoo.comStarpharma signs new DEP® agreement with MSDAugust 10, 2022 | finance.yahoo.comStarpharma: VIRALEZE Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral ExposureJuly 20, 2022 | finanznachrichten.deStarpharma Holdings Ltd. ADR (SPHRY)January 12, 2022 | nasdaq.comWhat is happening to the Starpharma (ASX:SPL) share price today?December 13, 2021 | msn.comStarpharma (ASX:SPL) share price shoots 6% higher on Roche agreementDecember 6, 2021 | msn.comWhy is the Starpharma (ASX:SPL) share price trading at 52-week lows?November 19, 2021 | msn.comPerth businesswoman Kim Tran launches new business, scores supply deal with StarpharmaOctober 28, 2021 | markets.businessinsider.comStarpharma (ASX:SPL) share price lifts on supply and distribution dealOctober 26, 2021 | msn.comVIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in ItalyOctober 8, 2021 | finance.yahoo.comUS Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma’s phase 2 clinical-stage cancer treatmentsSeptember 15, 2021 | apnews.comUS Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatmentsSeptember 15, 2021 | finance.yahoo.comStarpharma (ASX:SPL) share price tanks 3% on 67% revenue dropAugust 26, 2021 | msn.comWhy the Starpharma (ASX:SPL) share price is racing 7% higher todayJuly 26, 2021 | msn.com Get Starpharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SPHRY and its competitors with MarketBeat's FREE daily newsletter. Email Address SPHRY Media Mentions By Week SPHRY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPHRY News Sentiment▼-1.000.72▲Average Medical News Sentiment SPHRY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPHRY Articles This Week▼10▲SPHRY Articles Average Week Get Starpharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SPHRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NOTV News Today BIOQ News Today CBWTF News Today ONMD News Today LUNA News Today BIAF News Today FOXO News Today ISPC News Today DNAG News Today USRM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SPHRY) was last updated on 1/31/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Starpharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Starpharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
